The Effects of MeOH Extract of Hopea chinensis (Merr.) Hand.-Mazz. on the Metabolism of Amyloid Precursor Protein in Neuroblastoma Cells
![]() |
Chandra, Shrestha Abinash
(College of Pharmacy, Woosuk University)
Kim, Ju Eun (College of Pharmacy, Woosuk University) Ham, Ha Neul (College of Pharmacy, Woosuk University) Jo, Youn Jeong (College of Pharmacy, Woosuk University) Bach, Tran The (Institute of Ecology and Biological Resources (IEBR), Vietnam Academy of Science and Technology (VAST)) Eum, Sang Mi (Korea Research Institute of Bioscience & Biotechnology (KRIBB)) Leem, Jae Yoon (College of Pharmacy, Woosuk University) |
1 | Harun A., Muhammad J. J. R., Lim S. M, Bakar A. M. A., Cole A. L. J. and Ramasamy K. (2011) BACE1 inhibitory activity of fungal endophytic extracts from Malaysian medicinal plants. BMC Complement Altern. Med. 11: 79. DOI |
2 | Selkoe, D. J. (1998) The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8: 447-453. DOI |
3 | Strittmatter, W. J., Weisgraber, K. H. Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D. and Roses, A. D. (1993) Binding of human apolipoprotein E to synthetic amyloid beta peptide isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 8098-8102. DOI |
4 | Leem, J. Y., Saura, C. A., Pietrzik, C., Christianson, J., Wanamaker, C., King, L. T., Veselits, M. L., Tomita, T., Gasparini, L., Iwatsubo, T., Xu, H., Green, W. N., Koo, E. H. and Thinakaran, G. (2002) A role for presenilin 1 in regulating the delivery of amyloid precursor protein to the cell surface. Neurobiol. Dis. 11: 64-82. DOI |
5 | Fu, H., Dou, J., Li, W., Cui, W., Mak, S., Hu, Q., Luo, J., Lam, C. S., Pang, Y., Youdim, M. B. and Han, Y. (2009) Promising multifunctional anti-Alzheimer's dimer bis(7)-Cognitin acting as an activator of protein kinase C regulates activities of alpha-secretase and BACE-1 concurrently. Eur. J. Pharmacol. 623: 14-21. DOI |
6 | Sugimoto, H. (2001) Donepezil hydrochloride. a treatment drug for Alzheimer's disease. Chem. Rec. 1: 63-73. DOI |
7 |
Cai, H., Wang, Y., McCarthy, D., Wen, H., Borchelt, D. R., Price, D. L. and Wong, P. C. (2001) BACE1 is the major |
8 | Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A .D., Haines, J. L. and Pericak-Vance, M. A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923. DOI |
9 |
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M. A., Biere, A. L., Curran, E., Burgess, T., Louis, J. C., Collins, F., Treanor, J., Rogers, G. and Citron, M. (1999) |
10 | Selkoe, D. J. (1999) Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399: 23-31. DOI |
11 | 통계청 자료(http://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1B35001) |
12 | 1. Yan, T., Wang, T., Wei, W., Jiang, N., Qin, Y. H., Tan, R. X. and Ge, H. M. (2012) Polyphenolic acetylcholinesterase inhibitors from Hopea chinensis. Planta Med. 78: 1015-1019. DOI |
13 | Zarotsky, V., Sramek, J. J. and Cutler, N. R. (2003) Galantamine hydrobromide. an agent for Alzheimer's disease. Am. J. Health Syst. Pharm. 60: 446-452. |
14 | Jann, M. W. (2000) Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease. Pharmacotherapy 20: 1-12. DOI |
15 | Ge, H. M., Zhu, C. H., Shi, D. H., Zhang, L. D., Xie, D. Q., Yang, J., Ng, S. W. and Tan RX. (2008) Hoeahainol A: an acetylcholinesterase inhibitor from Hopea hainanensis. Chem. Eur. J. 14: 376-381. DOI |
16 | Ge, H. M., Yang, W. H., Shen, Y., Jiang, N., Guo, Z.K., Luo. Q., Xu, Q., Ma, J. and Tan, R. X. (2010) Immunosuppressive resveratrol aneuploids from Hopea chinensis. Chemistry. 16: 6338-6345. DOI |
17 |
Wang, R., Sweeney, D., Gandy, S. E. and Sissodia, S. S. (1996) The profile of soluble amyloid |
18 | Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-Wood, K., Lee, M., Seubert, P., Davis, A., Kholodenko, D., Motter, R., Sherrington, R., Perry, B., Yao, H., Strome, R., Lieberburg, I., Rommens, J., Kim, S., Schenk, D., Fraser, P., St George Hyslop, P. and Selkoe. D. J. (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat. Med. 3: 67-72. DOI |
19 | Morris, J. C. (1996) Classification of dementia and Alzheimer's disease. Acta Neurol. Scand. 165: 41-50. |
20 | Nunan, J. and Small, D. H. (2000) Regulation of APP cleavage by alpha-, beta- and gamma-secretases. FEBS Lett. 483: 6-10. DOI |
21 | Kuo, Y. M., Emmerling, M. R., Vigo-Pelfrey, C., Kasunic, T. C., Kirkpatrick, J. B., Murdoch, G. H., Ball, M. J. and Roher, A. E. (1996) Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem. 271: 4077-4081. DOI |
22 | Takahashi, Y., Hayashi, I., Tominari, Y., Rikimaru, K., Morohashi, Y., Kan, T., Natsugari, H., Fukuyama, T., Tomita, T. and Iwatsubo, T. (2003) Sulindac sulfide is a noncompetitive gamma-secretase inhibitor that preferentially reduces Abeta 42 generation. J. Biol. Chem. 278: 18664-18670. DOI |
23 | Uchida N, Takasaki K, Sakata Y, Nogami A, Oishi H, Watanabe T, Shindo T, Egashira N, Kubota K, Katsurabayashi S, Mishima K, Fujiwara M, Nishimura R, Iwasaki K. (2013) Cholinergic involvement and synaptic dynamin 1 expression in Yokukansan-mediated improvement of spatial memory in a rat model of early Alzheimer's disease. Phytother. Res. 27: 966-972. DOI |
24 |
Obregon, D., Hou, H., Deng, J., Giunta, B., Tian, J., Darlington, D., Shahaduzzaman, M., Zhu, Y., Mori, T., Mattson, MP. and Tan, J. (2012) Soluble amyloid precursor protein- |
25 | Skovronsky, D. M., Moore, D. B., Milla, M. E., Doms, R. W. and Lee, V. M. (2000) Protein kinase C-dependent alpha-secretase competes with beta-secretase for cleavage of amyloid-beta precursor protein in the trans-golgi network. J. Biol. Chem. 275: 2568-2575. DOI |
26 | Tung, J. S., Davis, D. L., Anderson, J. P., Walker, D. E., Mamo, S., Jewett, N., Hom, R. K., Sinha, S. and Thorsett, E. D., John, V. (2002) Design of substrate-based inhibitors of human beta-secretase. J. Med. Chem. 45: 259-262. DOI |
27 | Iqbal, K., Sisodia, S. S. and Winblad, B. (2001) Alzheimer's disease. Advances in etiology, pathogenesis and therapeutics. John Wiley & Sons, Ltd. |
28 | Li, N., Zhou, L., Li, W., Liu, Y., Wang, J. and He, P. (2015) Protective effects of ginsenosides Rg1 and Rb1 on an Alzheimer's disease mouse model: A metabolomics study. J. Chromatogr. B Analyt.. Technol. Biomed. Life Sci. 985: 54-61. DOI |
29 | Hardy, J. and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356. DOI |
30 |
Steiner, H., Winkler, E., Edbauer, D., Prokop, S., Basset, G., Yamasaki, A., Kostka, M. and Haass, C. (2002) PEN-2 is an integral component of the |
31 | Sambamurti, K., Hardy, J., Refolo L. M. and Lahiri, D. K. (2002) Targeting APP metabolism for the treatment of Alzheimer's disease. Drug Dev. Res. 56: 211-227. DOI |
![]() |